Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2014
05/13/2014US8722861 Monoclonal antibodies that bind to the V3 loop of HIV-1 gp120
05/13/2014US8722860 Anti-TNF-α antibodies and their uses
05/13/2014US8722859 Multivalent antibodies and uses therefor
05/13/2014US8722858 Anti-Prominin-1 antibody having ADCC activity or CDC activity
05/13/2014US8722857 Anti-CD79B antibodies and immunoconjugates and methods of use
05/13/2014US8722856 Anti-MUC1 antibody
05/13/2014US8722855 Dual variable domain immunoglobulins and uses thereof
05/13/2014US8722637 Methods and compositions of IG20 and DENN-SV splice variants
05/13/2014US8722629 Auristatin derivatives and use thereof
05/13/2014US8722344 Risk markers for cardiovascular disease
05/13/2014US8722341 Metapneumovirus strains and their use in vaccine formulations and sequences
05/13/2014US8722055 Synthetic Streptococcus pneumoniae vaccine
05/13/2014US8722053 IgE CH3 peptide vaccine
05/13/2014US8722051 Tweak receptor
05/13/2014US8722047 Humanized anti-HLA-DR antibodies
05/13/2014US8722044 Human tissue factor antibody and uses thereof
05/13/2014US8722043 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
05/13/2014US8722042 Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease
05/13/2014US8722041 Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof
05/13/2014US8722033 Human IL-23 antigen binding proteins
05/13/2014CA2715324C Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
05/13/2014CA2627457C Botulinum neurotoxin a protein receptor and uses thereof
05/13/2014CA2615776C Secretion of antibodies without signal peptides from bacteria
05/13/2014CA2546054C Interferon alpha antibodies and their uses
05/13/2014CA2516349C Delta-endotoxin genes and methods for their use
05/08/2014WO2014071212A2 Stable dual variable domain immunoglobulin protein formulations
05/08/2014WO2014071074A2 Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
05/08/2014WO2014071015A1 Erythroferrone and erfe polypeptides and methods of regulating iron metabolism
05/08/2014WO2014070957A1 Antibody/drug conjugates and methods of use
05/08/2014WO2014070939A1 Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
05/08/2014WO2014070934A1 Anti-cd40 antibodies and methods of use
05/08/2014WO2014070874A1 Methods for modulating immune responses during chronic immune conditions by targeting il-27 induced pathways
05/08/2014WO2014070786A1 Compositions and methods for inhibiting pathogen infection
05/08/2014WO2014070635A1 Compositions and methods for the treatment of systemic inflammatory response syndromes
05/08/2014WO2014070117A1 Monoclonal antibody against muramyl peptides
05/08/2014WO2014070109A1 An enterovirus 71 specific antibody
05/08/2014WO2014069757A1 Stabilizer for hyaluronidase and liquid formulation comprising hyaluronidase
05/08/2014WO2014069682A1 Cancer-targeting antibody and composition for preventing or treating cancer comprising same
05/08/2014WO2014069681A1 Cancer-targeting antibody and composition for preventing or treating cancer comprising same
05/08/2014WO2014069647A1 Antibody and antibody composition production method
05/08/2014WO2014068300A1 Anti-s100a4 antibody molecules and their uses
05/08/2014WO2014068139A1 Novel antigen binding proteins and their use as addressing product for the treatment of cancer
05/08/2014WO2014068132A1 Binding members to il-1 beta
05/08/2014WO2014068079A1 An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
05/08/2014WO2014068026A1 Liquid formulation comprising gm-csf neutralizing compound
05/08/2014WO2014068021A1 Method for preparation of a high concentration liquid formulation of an antibody
05/08/2014WO2014067642A1 Method for the production of multispecific antibodies
05/08/2014WO2014067011A1 Crystal structures of heterodimeric fc domains
05/08/2014WO2014043484A3 Metabolic remodeling of the tumor microenvironment: migration stimulating factor (msf) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth
05/08/2014WO2014036495A4 Diagnostic assays and kits for detection of folate receptor 1
05/08/2014WO2014031630A3 Antibodies to paliperidone and use thereof
05/08/2014WO2014028509A3 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
05/08/2014WO2014008406A3 The bacterial biofilm matrix as a platform for protein delivery
05/08/2014WO2013188448A8 Dual receptor antagonistic antigen-binding proteins and uses thereof
05/08/2014WO2013070619A8 Indolealkylamino-withasteroid conjugates and method of use
05/08/2014WO2013049517A3 Therapeutic peptides
05/08/2014WO2013043070A9 Anti-tumor necrosis factor-alpha agents and uses thereof
05/08/2014WO2013012743A3 Methods and compositions for inhibiting staphylococcus agglutination in blood
05/08/2014WO2012158945A3 Compositions and methods for treating charcot-marie-tooth diseases and related neuronal diseases
05/08/2014US20140130194 Mice that make vl binding proteins
05/08/2014US20140130193 Mice that make vl binding proteins
05/08/2014US20140130192 Nucleic Acid Encoding a Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof
05/08/2014US20140128590 Hydrolases, nucleic acids encoding them and methods for making and using them
05/08/2014US20140128580 Antibody-drug conjugates and methods
05/08/2014US20140128579 Specific delivery of agrochemicals
05/08/2014US20140128577 Purification of chimeric protein
05/08/2014US20140128576 Anti-IL-23 Antibodies, Compositions, Methods and Uses
05/08/2014US20140128575 Prevention of disulfide bond reduction during recombinant production of polypeptides
05/08/2014US20140128447 Novel non-primate hepacivirus
05/08/2014US20140127743 Methods for producing recombinant proteins
05/08/2014US20140127704 Kit for diagnosing cardiomyopathy and method for predicting cardiomyopathy
05/08/2014US20140127250 Staphylococcus aureus proteins and nucleic acids
05/08/2014US20140127244 Vaccines for suppressing ige-mediated allergic disease and methods for using the same
05/08/2014US20140127243 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127242 Novel and powerful mhc-class ii peptides derived from survivin
05/08/2014US20140127238 Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response
05/08/2014US20140127237 Anti-Mesothelin Antibodies
05/08/2014US20140127236 Humanised anti-cd52 antibodies
05/08/2014US20140127234 Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
05/08/2014US20140127230 Antibodies to tgf-beta
05/08/2014US20140127227 Protein formulations containing amino acids
05/08/2014US20140127226 T Cell Regulation
05/08/2014US20140127225 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
05/08/2014US20140127224 Therapeutic Method
05/08/2014US20140127223 Anti-human receptor-type protein tyrosine phosphatase sigma antibody
05/08/2014US20140127221 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
05/08/2014US20140127220 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection
05/08/2014US20140127219 Antibodies for treatment of cancer
05/08/2014US20140127218 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127217 Pharmaceutical compositions and methods to vaccinate against candidiasis
05/08/2014US20140127216 Novel expression cassette for efficient surface display of antigenic proteins
05/08/2014US20140127215 Clostridium difficile antigens
05/08/2014US20140127214 Natural igm antibodies and inhibitors thereof
05/08/2014US20140127212 Binding Members For IgE Molecules
05/08/2014US20140127211 Anti-notch3 antibodies and antibody-drug conjugates
05/08/2014US20140127210 Bispecific antigen binding protein complex and preparation methods of bispecific antibodies
05/08/2014US20140127209 Antibody derivatives
05/08/2014US20140127208 Anti-Complement C1s Antibodies and Uses Thereof
05/08/2014US20140127207 Antibodies against epidermal growth factor receptor (egfr) and uses thereof
05/08/2014US20140127206 Methods of treating pain using an il-31 monoclonal antibody
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 1494